The diagnostic problems in patient with ascites, elevated Ca 125 level and autoantibodies against nuclear antigens and smooth muscle antigens mimicking advanced ovarian carcinoma - Case study

Ginekologia Polska

Volumn 79, Issue 5, 2008, Pages 375-377

  Szajnik, Marta ^a   Nowak Markwitz, Ewa ^a   Szczepański, Mirosław ^a   Spaczyński, Marek ^a   Linke, Krzysztof ^a   Zeromski, Jan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ascites; Autoantibodies; CA 125 antigen; Ovarian neoplasms

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CA 125 ANTIGEN;

ADULT; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BLOOD; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOLOGY; OVARY TUMOR; SMOOTH MUSCLE;

ADULT; ASCITES; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MUSCLE, SMOOTH; OVARIAN NEOPLASMS;

EID: 48549094466     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Daoud E, Bodor G. CA-125 concentrations in malignant and nonmalignant disease. Clin Chem. 1991, 37, 1968-1974.
2. Bergmann J, Bidart J, George M, [et al.]. Elevation of CA 125 in patients with benign and malignant ascites. Cancer. 1987, 59, 213-217.
3. Eltabbakh G, Belinson J, Kennedy A, [et al.]. Serum CA-125 measurements > 65 U/mL. Clinical value. J Reprod Med. 1997, 42, 617-624.
4. Lernmark A. Autoimmune diseases: are markers ready for prediction? J Clin Invest. 2001, 108, 1091-1096.
5. Topalak O, Saygili U, Soyturk M, [et al.]. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol. 2002, 85, 108-113.
6. Ben-Ari Z, Czaja A. Autoimmune hepatitis and its variant syndromes. Gut. 2001, 49, 589-594.